Ligand Pharmaceuticals (LGND) Assets (2010 - 2026)
Ligand Pharmaceuticals' Assets came in at $2.19 billion for Q2 2026, up 130.4% from $948.6 million a year earlier and up 42.7% from the prior quarter.
Analysis
Ligand Pharmaceuticals (LGND) Assets (2010 - 2026) Analysis & Trends
At the end of FY2025, Ligand Pharmaceuticals' Assets was $1.56 billion, up 65.7% from FY2024.
- Assets has increased in each of the last three years, with a five-year compound annual growth rate of 2.8% (FY2020 to FY2025).
- Going back by year, Assets was $941.77 million in FY2024 (+19.6%), $787.22 million in FY2023 (+3.2%), $762.67 million in FY2022 (-41.2%) and $1.3 billion in FY2021 (-4.7%).
- The Q2 2026 figure represents the highest quarterly Assets in data going back to Q4 2010.
- Year-over-year, Assets has increased for five consecutive quarters, with growth averaging 46.5% over the last eight quarters.
- The fastest year-over-year change in Assets over five years came in Q2 2026 (growth of 130.4%), and the weakest in Q4 2022 (a decline of 41.2%).
- Business Quant data shows LGND's Assets at $1.53 billion (Q1 2026), $1.56 billion (Q4 2025) and $1.48 billion (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 201.06 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 135.12 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 129.80 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 122.03 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 115.83 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 95.64 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 49.36 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 201.13 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 27.42 Bn |
| 10 | Ligand Pharmaceuticals | 6.26 Bn | 2.72 Bn | - | 2.19 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.19 Bn |
| Mar 31, 2026 | 1.53 Bn |
| Dec 31, 2025 | 1.56 Bn |
| Sep 30, 2025 | 1.48 Bn |
| Jun 30, 2025 | 948.60 Mn |
| Mar 31, 2025 | 905.44 Mn |
| Dec 31, 2024 | 941.77 Mn |
| Sep 30, 2024 | 954.87 Mn |
| Jun 30, 2024 | 866.41 Mn |
| Mar 31, 2024 | 913.87 Mn |
| Dec 31, 2023 | 787.22 Mn |
| Sep 30, 2023 | 769.23 Mn |
| Jun 30, 2023 | 758.11 Mn |
| Mar 31, 2023 | 811.08 Mn |
| Dec 31, 2022 | 762.67 Mn |
| Sep 30, 2022 | 1.05 Bn |
| Jun 30, 2022 | 1.08 Bn |
| Mar 31, 2022 | 1.11 Bn |
| Dec 31, 2021 | 1.30 Bn |
| Sep 30, 2021 | 1.27 Bn |
API Access
Ligand Pharmaceuticals Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=assets&ticker=LGND&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "assets", "ticker": "LGND", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=assets&ticker=LGND&period=max&api_key=YOUR_API_KEY");
const data = await res.json();